Effects of IGF-1 on deexy-D-glucose uptake by human peripheral blood lymphocytes

Diabetologia Doswiadczalna i Kliniczna

Volumn 6, Issue 6, 2006, Pages 314-319

  Pliszka, Monika ^a,b   Szablewski, Leszek ^a   Oleszczak, Bozenna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Deoxy D glucose; Glucose transporters; IGF 1 (insulin like growth factor 1); Insulin receptor; Insulin resistance

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; INSULIN; SOMATOMEDIN C;

ADULT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INSULIN RESISTANCE; LYMPHOCYTE; PERIPHERAL LYMPHOCYTE;

EID: 33947218833     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Whitehead JP, Soos MA, Jackson R, Tasic V, Kocova M, O'Rhilly S. Multiple molecular mechanism of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes 1998; 47: 1362-1364.
2. Pamiȩta M, Szablewski L. Insulinooporność powodowana mutacjami w genie receptora insuliny. Diabetol Pol 2003; 10: 417-421.
3. Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 2004; 113: 25-27.
4. Hussain MA, Froesch ER. Treatment of type A insulin resistance with insulin-like growth factor-1. Lancet 1993; 341: 1536-1537.
5. Thrailkill KM. Insulin-like growth factor-1 in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Therap 2000; 2: 69-80.
6. Takahashi Y, Kodowaki H, Mamamura K. A homozygous kinase - defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia 1997; 40: 412-420.
7. Maassen JA Van der Vorm ER, Van der Zon GC, Klinkhamer MP, Krans HM, Moller W. A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochem 1991; 30: 10778-10783.
8. Backeljauw PF, Alves C, Eidson M, Cleveland W, Clinderwood LE, Davenport ML. Effect of intravenous insulin-like growth factor 1 in two patients with leprechaunism. Ped Res 1994; 36: 749-754.
9. Hirano T, Adachi M. Insulin-like growth factor 1 therapy for type B insulin resistance. Am Int Med 1997; 127: 245-246.
10. Longo N, Singh R, Griffin LD, Langley SD, Parks JS, Elsas LJ. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I. J Clin Endocrinol Metabol 1994; 79: 799-805.
11. Ando A. Rabson-Mendenhall syndrome. Jap J Clin Med 1994, 52; 2641-2642.
12. Szablewski L, Pia̧tkiewicz P, Oleszczak B, Nowak Ł, Sobczyk A, Grytner-Ziȩcina B. Wpływ leczenia insulina̧ chorych na cukrzycȩ typu 2 na pobieranie deoksy-D-glukozy przez limfocyty krwi obwodowej. Diab Dośw i Klin 2004; 4: 217-223.
13. Bilan PJ, Mitsumoto Y, Ramlal T, Klip A. Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells. Translocation and biosynthesis. FEBS Letters 1992; 298: 285-290.
14. Gherzi R, Meliolo G, de Luca M et al. HepG2/erythroid/brain type glucose transporter (GLUT 1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT 1 levels in reconstituted epidermis. J Cell Physiol 1992; 150: 463-474.
15. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29: 691-699.
16. Debosch BJ, Deo BK, Kumagai AK. Effect of insulin-like growth factor I on retinal endothelial cell glucose transport and proliferation: role of PI3 kinase and protein kinase C. Diabetes 2000; suppl. 1: A49.
17. Heilig CW, Liu Y, England RL. et al. D-glucose stimulates mesangial cell GLUT 1 expression and basal and IGF-1 sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes 1997; 46: 1030-1039.
18. Kamp GA, Ouwens DM, Hoogerbrugge CM, Zwinderman AH, Maassen JA, Wit JM. Skin fibroblasts of children with idiopathic short stature show an increased mitogenic response to IGF-1 and secrete more IGFBP-3. Clin Endocrinol 2002; 56: 439-447.
19. Kaliman P, Vińals F, Testar X, Palacin M, Zorzano A. Disruption of Glut 1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmanin. Biochem J 1995; 312: 471-477.
20. Pia̧tkiewicz P, Szablewski L, Czech A, Tatoń J, Oleszczak B, Kasprzycka M. Badania transportu glukozy do limfocytów osób zdrowych i chorych na cukrzycȩ typu 2. Med Metabol 2002; 6: 15-21.
21. Szablewski L, Oleszczak B, Malejczyk J, Osiecka A, Hyc A, Borsuk P. Facilitative glucose transporters in rat chondrocytes. Eur J Cell Biol 2000; suppl. 52: 113.
22. Bilan PJ, Mitsumoto Y, Maher F, Simpson IA, Klip A. Detection of GLUT 3 facilitative glucose transporter in rat L6 muscle cells: regulation by cellular differentiation, insulin and insulin-like growth factor-1. Biochem Biophys Res Commun 1992; 186: 1128-1137.
23. Stuart C, Copland J, Wood T, Green A. Human GLUT 3 gene structure. Diabetes 2001; suppl. 2: A227.
24. Russo D, Damante G, Foti D, Constante G, Filetti S. Different molecular mechanisms are involved in multihormonal control of glucose transport in FRTL5 rat thyroid cells. J Endoc Invest 1994; 17: 323-327.
25. Shen S, Wertheimer E, Sampson SR, Tennenbaum T. Characterization of glucose transport system in keratinocytes: insulin and IGF-1 differentially affect specific transporters. J Invest Dermatol 2000; 115: 949-954.
26. Verleysdonk S, Hirschner W, Wellard J et al. Regulation by insulin and insulin-like growth factor of 2-deoxyglucose up-take in primary ependymal cell cultures. Neurochem Res 2004; 29: 127-134.
27. Fladeby C, Bjonness B, Serck-Hanssen G. GLUT1-mediated glucose transport and its regulation by IGF-1 in cultured bovine chromaffin cells. J Cell Physiol 1996; 169: 242-247.
28. Teruel T, Valverde AM, Benito M, Lorenzo M. Insulin-like growth factor I and insulin induce adipogenic-related gene expression in fetal brown adipocyte primary cultures. Biochem J 1996; 319: 627-632.
29. Doege H, Bocianski A, Joost HG, Schurmann A. Activity and genomic organization of human glucose transporter 9 (GLUT 9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 2000; 350: 771-776.
30. Thrailkill KM. Insulin-like growth factor-1 in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Therap 2000; 2: 69-80.